These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 9626331

  • 1. The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c mice.
    Rosenblatt-Bin H, Kalechman Y, Vonsover A, Xu RH, Da JP, Shalit F, Huberman M, Klein A, Strassmann G, Albeck M, Sredni B.
    Cell Immunol; 1998 Feb 25; 184(1):12-25. PubMed ID: 9626331
    [Abstract] [Full Text] [Related]

  • 2. Antibabesial effect of the immunomodulator AS101 in mice: role of increased production of nitric oxide.
    Rosenblatt-Bin H, Klein A, Sredni B.
    Parasite Immunol; 1996 Jun 25; 18(6):297-306. PubMed ID: 9229382
    [Abstract] [Full Text] [Related]

  • 3. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101.
    Sredni B, Tichler T, Shani A, Catane R, Kaufman B, Strassmann G, Albeck M, Kalechman Y.
    J Natl Cancer Inst; 1996 Sep 18; 88(18):1276-84. PubMed ID: 8797767
    [Abstract] [Full Text] [Related]

  • 4. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
    Kalechman Y, Rushkin G, Nerubay J, Albeck M, Sredni B.
    Exp Hematol; 1995 Dec 18; 23(13):1358-66. PubMed ID: 7498364
    [Abstract] [Full Text] [Related]

  • 5. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.
    Kalechman Y, Gafter U, Gal R, Rushkin G, Yan D, Albeck M, Sredni B.
    J Immunol; 2002 Jul 01; 169(1):384-92. PubMed ID: 12077268
    [Abstract] [Full Text] [Related]

  • 6. Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: role in the antitumoral effects of AS101.
    Kalechman Y, Sredni B.
    J Immunol; 1996 Jul 15; 157(2):589-97. PubMed ID: 8752906
    [Abstract] [Full Text] [Related]

  • 7. Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties.
    Kalechman Y, Shani A, Albeck M, Sredni B.
    Immunopharmacology; 1995 Mar 15; 29(2):149-58. PubMed ID: 7539780
    [Abstract] [Full Text] [Related]

  • 8. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate.
    Kalechman Y, Zuloff A, Albeck M, Strassmann G, Sredni B.
    Blood; 1995 Mar 15; 85(6):1555-61. PubMed ID: 7888674
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Macrophages are critical for cross-protective immunity conferred by Babesia microti against Babesia rodhaini infection in mice.
    Li Y, Terkawi MA, Nishikawa Y, Aboge GO, Luo Y, Ooka H, Goo YK, Yu L, Cao S, Sun Y, Yamagishi J, Masatani T, Yokoyama N, Igarashi I, Xuan X.
    Infect Immun; 2012 Jan 15; 80(1):311-20. PubMed ID: 22064713
    [Abstract] [Full Text] [Related]

  • 11. Primary Babesia rodhaini infection followed by recovery confers protective immunity against B. rodhaini reinfection and Babesia microti challenge infection in mice.
    Wang G, Efstratiou A, Adjou Moumouni PF, Liu M, Jirapattharasate C, Guo H, Gao Y, Cao S, Zhou M, Suzuki H, Igarashi I, Xuan X.
    Exp Parasitol; 2016 Oct 15; 169():6-12. PubMed ID: 27423972
    [Abstract] [Full Text] [Related]

  • 12. Protective and restorative role of AS101 in combination with chemotherapy.
    Kalechman Y, Albeck M, Oron M, Sobelman D, Gurwith M, Horwith G, Kirsch T, Maida B, Sehgal SN, Sredni B.
    Cancer Res; 1991 Mar 01; 51(5):1499-503. PubMed ID: 1997189
    [Abstract] [Full Text] [Related]

  • 13. Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels.
    Kalechman Y, Gafter U, Da JP, Albeck M, Alarcon-Segovia D, Sredni B.
    J Immunol; 1997 Sep 15; 159(6):2658-67. PubMed ID: 9300685
    [Abstract] [Full Text] [Related]

  • 14. Helper T cell and antibody responses to infection of CBA mice with Babesia microti.
    Chen D, Copeman DB, Burnell J, Hutchinson GW.
    Parasite Immunol; 2000 Feb 15; 22(2):81-8. PubMed ID: 10652120
    [Abstract] [Full Text] [Related]

  • 15. The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody.
    Blank M, Sredni B, Albeck M, Mozes E, Shoenfeld Y.
    Clin Exp Immunol; 1990 Mar 15; 79(3):443-7. PubMed ID: 2317948
    [Abstract] [Full Text] [Related]

  • 16. Radioprotective effects of the immunomodulator AS101.
    Kalechman Y, Albeck M, Oron M, Sobelman D, Gurwith M, Seghal SN, Sredni B.
    J Immunol; 1990 Sep 01; 145(5):1512-7. PubMed ID: 2384668
    [Abstract] [Full Text] [Related]

  • 17. Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection.
    Klein TW, Newton CA, Nakachi N, Friedman H.
    J Immunol; 2000 Jun 15; 164(12):6461-6. PubMed ID: 10843702
    [Abstract] [Full Text] [Related]

  • 18. The cytoprotective effect of the immunomodulator AS101 against hydrochloride induced gastric lesions.
    Xu RH, Kalechman Y, Albeck M, Sredni B.
    Res Commun Mol Pathol Pharmacol; 1995 Jan 15; 87(1):4-20. PubMed ID: 7735728
    [Abstract] [Full Text] [Related]

  • 19. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.
    O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML.
    Ann Surg; 1995 Oct 15; 222(4):482-90; discussion 490-2. PubMed ID: 7574928
    [Abstract] [Full Text] [Related]

  • 20. The tellurium redox immunomodulating compound AS101 inhibits IL-1β-activated inflammation in the human retinal pigment epithelium.
    Ling D, Liu B, Jawad S, Thompson IA, Nagineni CN, Dailey J, Chien J, Sredni B, Nussenblatt RB.
    Br J Ophthalmol; 2013 Jul 15; 97(7):934-8. PubMed ID: 23624272
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.